thioridazine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Y | 1 |
| Li, L | 1 |
| Chen, J | 1 |
| Chen, H | 1 |
| Cui, B | 1 |
| Feng, Y | 1 |
| Zhang, P | 1 |
| Zhang, Q | 1 |
| Xia, Y | 1 |
| Luo, M | 1 |
1 other study available for thioridazine and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0/G1 arrest and apoptosis.
Topics: Animals; Antipsychotic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell | 2020 |